1. Determination the levels of Bone Morphogentic Protein-2, P-selectin, substance P in β-Thalassemia major in Iraqi patients
- Author
-
Hussein Jassim Al-Harbi and Noor Ali Hussein
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Blood transfusion ,biology ,P-selectin ,business.industry ,medicine.medical_treatment ,Thalassemia ,Beta thalassemia ,Substance P ,Disease ,medicine.disease ,Ferritin ,chemistry.chemical_compound ,chemistry ,hemic and lymphatic diseases ,Internal medicine ,biology.protein ,Medicine ,Pharmacology (medical) ,Family history ,business ,Pharmacology, Toxicology and Pharmaceutics (miscellaneous) - Abstract
The current study aimed to assess BMP-2, P-selectin, substance-p in s-thalassemia major patients in Babylon Province (Iraq), by enrolling individual of Arab ancestry. A total of 70 beta-thalassemia major patients and 30 normal individual were enrolled Family history. All patients were blood transfusion depend with age mean (14.1±0.7years). On the other hand the selected control do not have history of family for thalassemia and doesn’t have any disease with mean age (15.6±1.2years). The result revealed significant decrease in BMP-2 in beta-thalassemia major patients, and significant increase in P-selectin, substance P in beta-thalassemia major patients.
- Published
- 2019
- Full Text
- View/download PDF